Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear DNA is the primary repository of genetic information in eukaryotic cells and serves as the fundamental molecular target for platinum-based chemotherapeutic agents like oxaliplatin (StatPearls, NBK542163). Oxaliplatin exerts its anti-tumor activity by forming covalent bonds with DNA bases, specifically creating 1,2-intrastrand crosslinks between adjacent guanine residues (PubChem, CID 43805). These platinum-DNA adducts cause significant structural distortion of the double helix, which physically blocks the progression of DNA and RNA polymerases. In rapidly dividing tumor cells, these lesions lead to replication fork stall, DNA strand breaks, and the activation of apoptotic signaling pathways (PubMed, 17513805). While highly effective in treating malignancies such as colorectal cancer, the non-specific targeting of DNA in all proliferating cells contributes to systemic toxicities, including neurotoxicity and bone marrow suppression (NIH, NCI Dictionary).
Oxaliplatin undergoes non-enzymatic conversion into active derivatives that covalently bind to the N7 position of guanine and adenine residues in nuclear DNA. This binding forms 1,2-intrastrand crosslinks, 1,3-intrastrand crosslinks, and interstrand crosslinks, which physically impede DNA polymerases and RNA polymerases, triggering cell cycle arrest and inducing apoptosis (StatPearls, NBK542163; PubChem, CID 43805).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear DNA (DNA) (DNA).